(Q33305144)

25 July 2017

title

What are the benefits of cognitive enhancers for Alzheimer's Disease: use of Population Impact Measures (English)

1 reference

25 July 2017

0 references

Richard F Heller

3

0 references

Alistair Burns

object named as

Alistair Burns

series ordinal

2

0 references

author name string

Udaya P Gammanpila

series ordinal

1

1 reference

25 July 2017

Nitin Purandare

series ordinal

4

1 reference

25 July 2017

language of work or name

1 reference

6 November 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

7

1 reference

25 July 2017

page(s)

25

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2318-7-25

25 July 2017

exact match

0 references

cites work

Prioritising between direct observation of therapy and case-finding interventions for tuberculosis: use of population impact measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Reaching the population with dementia drugs: what are the challenges?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Cholinesterase inhibitors for Alzheimer's disease: variations in clinical practice in the north-west of England.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Using economic analyses for local priority setting : the population cost-impact approach.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Helping to prioritise interventions for depression and schizophrenia: use of Population Impact Measures

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Donepezil for dementia due to Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Global prevalence of dementia: a Delphi consensus study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Non-drug therapies for dementia: an overview of the current situation with regard to proof of effectiveness.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Implementing guidelines in primary care: can population impact measures help?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Mild cognitive impairment in older people.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Impact numbers in health policy decisions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Disease impact number and population impact number: population perspectives to measures of risk and benefit

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Worldwide prevalence and incidence of dementia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206022

The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-7-25

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-7-25

Innovations: evidence-based practices: establishing the evidence base for psychiatric services: estimating the impact on the population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-7-25

Cognitive disability and direct care costs for elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-7-25

Economic impact of Alzheimer's disease in the United Kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-7-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-7-25

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-7-25

Commentary: relative treatment effects are consistent across the spectrum of underlying risks...usually

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17986333

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2318-7-25

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference